Ftse Mib
34.243,35
-0,39%
DAX
18.483,66
-0,63%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,00%
Bitcoin
63.759,10
-1,68%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
19/10/202315:26RNS Non-RegulatoryEvgen Pharma PLC Authored Article PublicationLSE:EVGEvgen Pharma Plc
05/09/202315:22Alliance NewsAlliance NewsEvgen Pharma hires interim CFO from Faron, chair to retire this monthLSE:EVGEvgen Pharma Plc
05/09/202308:00UK RegulatoryEvgen Pharma PLC Directorate ChangesLSE:EVGEvgen Pharma Plc
15/08/202311:01Alliance NewsAlliance NewsEvgen Pharma says trial shows new SFX-01 drug formulation is safeLSE:EVGEvgen Pharma Plc
15/08/202308:00UK RegulatoryEvgen Pharma PLC Final Report from Phase 1b PK/PD studyLSE:EVGEvgen Pharma Plc
03/08/202313:38UK RegulatoryEvgen Pharma PLC Rule 17 DisclosureLSE:EVGEvgen Pharma Plc
02/08/202311:28Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma shares drop on ending of license agreementLSE:EVGEvgen Pharma Plc
02/08/202308:00UK RegulatoryEvgen Pharma PLC Return of rights to Sulforadex from JuvenescenceLSE:EVGEvgen Pharma Plc
21/07/202313:03UK RegulatoryEvgen Pharma PLC Result of AGMLSE:EVGEvgen Pharma Plc
27/06/202311:01Alliance NewsAlliance NewsEvgen Pharma's SFX-01 has positive effects for treating a rare cancerLSE:EVGEvgen Pharma Plc
27/06/202308:00RNS Non-RegulatoryEvgen Pharma PLC SFX-01 radiosensitisation effect confirmed in-vivoLSE:EVGEvgen Pharma Plc
20/06/202314:59UK RegulatoryEvgen Pharma PLC Notice of AGM & Posting of Annual ReportLSE:EVGEvgen Pharma Plc
19/06/202311:05Alliance NewsAlliance NewsEvgen collaborator receives grant from KWF Dutch Cancer SocietyLSE:EVGEvgen Pharma Plc
19/06/202308:00UK RegulatoryEvgen Pharma PLC Grant Success for Glioblastoma studiesLSE:EVGEvgen Pharma Plc
07/06/202312:41Alliance NewsAlliance NewsEvgen Pharma confident amid Stalicla deal; CFO Moulson to retireLSE:EVGEvgen Pharma Plc
07/06/202308:00UK RegulatoryEvgen Pharma PLC Final ResultsLSE:EVGEvgen Pharma Plc
26/05/202312:00UK RegulatoryEvgen Pharma PLC Notice of ResultsLSE:EVGEvgen Pharma Plc
22/03/202312:10Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma shares up as pharmacokinetic data announcedLSE:EVGEvgen Pharma Plc
22/03/202308:00UK RegulatoryEvgen Pharma PLC Preliminary results from Phase 1b studyLSE:EVGEvgen Pharma Plc
16/03/202317:35Alliance NewsAlliance NewsEvgen notes evidence of radiosensitisation by SFX-01 in cancer cellsLSE:EVGEvgen Pharma Plc
16/03/202315:00UK RegulatoryEvgen Pharma PLC Price Monitoring ExtensionLSE:EVGEvgen Pharma Plc
16/03/202312:05UK RegulatoryEvgen Pharma PLC Second Price Monitoring ExtnLSE:EVGEvgen Pharma Plc
16/03/202308:00RNS Non-RegulatoryEvgen Pharma PLC Further evidence of radiosensitisation by SFX-01LSE:EVGEvgen Pharma Plc
13/03/202313:18Alliance NewsAlliance NewsSUMMARY: London listings with exposure to Silicon Valley BankLSE:EVGEvgen Pharma Plc
13/03/202308:00UK RegulatoryEvgen Pharma PLC No exposure to Silicon Valley BankLSE:EVGEvgen Pharma Plc
25/01/202311:40Alliance NewsAlliance NewsEvgen Pharma completes dosing of clinical trial for SFX-01 tabletLSE:EVGEvgen Pharma Plc
25/01/202308:00UK RegulatoryEvgen Pharma PLC Clinical trial updateLSE:EVGEvgen Pharma Plc
14/12/202218:08UK RegulatoryEvgen Pharma PLC Grant of Options - Director/PDMR ShareholdingLSE:EVGEvgen Pharma Plc
08/12/202214:57Alliance NewsAlliance NewsEvgen Pharma loss, operating expenses widen; SFX-01 study on scheduleLSE:EVGEvgen Pharma Plc
08/12/202208:00UK RegulatoryEvgen Pharma PLC Half-year ReportLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

NYSE
PSG
Performance Sports Group Ltd.
BIT
P1Y664
NLBNPIT1Y664 20240920 3
NYSE
DAL
Delta Air Lines
LSE
DPYE
Dm Ppty Eur-h
NASDAQ
LMNX
Luminex
COIN
XRPUSD
Ripple
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network